Regulatory 2020-10-21 | Upgraded estimate of addressable market for Mangoral to $500-600 million annually Download Presentation Webcast Excel
2020-09-30 | Invitation to Ascelia Pharma’s virtual Capital Markets Day Download Presentation Webcast Excel
Regulatory 2020-08-20 | Quarterly Report Q2-2020: First participant in the hepatic study Download Presentation Webcast Excel
Regulatory 2020-07-31 | Change in number of shares and votes in Ascelia Pharma AB Download Presentation Webcast Excel
Regulatory 2020-06-30 | Ascelia Pharma completes a directed new share issue of 4,697,781 shares, raising approximately SEK 98.7 million Download Presentation Webcast Excel
2020-06-09 | Presentation of Ascelia Pharma at ABGSC Life Science Summit Day and Redeye Orphan Drug Day Download Presentation Webcast Excel
Regulatory 2020-05-20 | Updated SPARKLE timelines due to Covid-19 impact Download Presentation Webcast Excel
Regulatory 2020-05-13 | Interim Financial Report Q1-2020: First patient enrolled in Phase 3 study SPARKLE Download Presentation Webcast Excel
Regulatory 2020-05-06 | Bulletin from the Annual General Meeting in Ascelia Pharma AB on 6 May 2020 Download Presentation Webcast Excel
